Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

SMP is a medical tattoo for hair loss, improving appearance and camouflaging scars, but requires skill and has limitations.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Using tissue expanders and hyaluronidase in scalp reduction surgery allows for more scalp removal and easier surgery.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Apoptosis contributes to hair loss in androgenetic alopecia.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

Scalp condition healed with prednisone and tacrolimus.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Cicatricial pemphigoid rarely affects the scalp but is hard to treat when it does.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

A man developed rare complications after nose surgery, stressing the need for better prevention.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

The new scalp coverage scoring method accurately measures hair loss and growth in men.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Minoxidil works better when applied on a damp scalp than a dry one.

A woman permanently lost hair on her scalp after a long surgery.

A new severe form of monilethrix syndrome includes hair loss, scalp itching, cataracts, and distinct facial features.

Inflammation may play a role in causing androgenetic alopecia.

Trichoscopy is useful for detecting and monitoring androgenetic alopecia.